FEED · XBRL financial data
ENvue Medical financial statements, every fiscal year
The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (FEED's year ends in late December)
| In thousands of dollars | Mar 31, 2021 | Dec 31, 2021 | †Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | †Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Revenue from contracts with customers | — | 1,695 | 752 | 2,283 | 2,558 | 2,553 |
| Cost of revenue | — | 925 | 585 | 746 | 1,050 | 2,400 |
| Gross profit | — | 770 | 167 | 1,537 | 1,508 | 153 |
| Research and development | — | 293 | 283 | 185 | 909 | 1,762 |
| General and administrative | — | 5,059 | 3,931 | 3,924 | 3,461 | 7,633 |
| Total operating expenses | — | 6,453 | 5,179 | 4,973 | 5,090 | 23,042 |
| Operating income (loss) | — | (5,683) | (5,012) | (3,436) | (3,582) | (22,889) |
| Interest expense | — | — | 347 | 135 | 135 | — |
| Income tax expense (benefit) | — | 32 | 35 | 29 | 19 | (307) |
| Net income (loss) | — | (14,282) | (5,448) | (3,711) | (3,705) | (18,185) |
| Earnings per share, basic USD per share | — | (11.35) | (3.84) | (2.12) | (13.73) | (26.69) |
| Earnings per share, diluted USD per share | — | — | (3.84) | (2.12) | (13.73) | (26.69) |
| Weighted average shares, basic thousands of shares | — | 1,258 | 1,420 | 1,750 | 270 | 629 |
| Weighted average shares, diluted thousands of shares | — | — | 1,420 | 1,750 | 270 | 629 |
- † Share count changed about 1/17 in the period ending 2022-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 5x in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Balance sheet
CSVFiscal years (FEED's year ends in late December)
| In thousands of dollars | Mar 31, 2021 | Dec 31, 2021 | †Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | †Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 7,953 | 7,737 | 2,713 | 3,283 | 752 | 4,224 |
| Accounts receivable | 26 | 200 | 9 | 318 | 98 | 289 |
| Inventory | 173 | 175 | 2,175 | 2,732 | 2,191 | 2,337 |
| Prepaid and other current assets | 180 | 230 | 712 | 154 | 290 | — |
| Total current assets | 8,357 | 8,342 | 5,609 | 6,487 | 3,331 | 7,271 |
| Property and equipment, net | 5 | 5 | 7 | 7 | 9 | 119 |
| Right-of-use asset | 25 | 49 | 81 | 5 | 116 | 127 |
| Goodwill | — | — | — | — | — | 29,082 |
| Total assets | 8,603 | 8,622 | 5,879 | 6,674 | 3,629 | 41,124 |
| Accounts payable | 102 | 87 | 66 | 138 | 47 | 719 |
| Total current liabilities | 876 | 1,903 | 2,316 | 2,454 | 2,722 | 6,660 |
| Lease liability, non-current | 14 | — | — | — | 64 | 28 |
| Total liabilities | 4,256 | 2,309 | 2,646 | 2,686 | 3,002 | 7,627 |
| Accumulated deficit | (47,572) | (56,937) | (62,385) | (66,096) | (69,801) | (90,481) |
| Total stockholders' equity | 4,347 | 6,313 | 3,233 | 3,988 | 627 | 33,497 |
| Total liabilities and equity | 8,603 | 8,622 | 5,879 | 6,674 | 3,629 | 41,124 |
| Common shares outstanding (cover page) thousands of shares | 24,110 | 27,998 | 1,662 | 2,784 | 759 | 3,701 |
- † Share count changed about 1/17 in the period ending 2022-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 5x in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Cash flows
CSVFiscal years (FEED's year ends in late December)
| In thousands of dollars | Mar 31, 2021 | Dec 31, 2021 | †Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | †Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Net income (loss) | — | (14,282) | (5,448) | (3,711) | (3,705) | (18,185) |
| Stock-based compensation | — | 382 | 354 | 293 | 356 | — |
| Depreciation and amortization | — | 2 | 1 | 1 | 1 | 897 |
| Net cash from operating activities | — | (4,367) | (7,035) | (3,602) | (2,516) | (9,372) |
| Purchases of property and equipment | — | 3 | 3 | 1 | 3 | 60 |
| Net cash from investing activities | — | (3) | (3) | (1) | (3) | 88 |
| Proceeds from issuing common stock | — | — | 2,090 | 4,215 | — | — |
| Proceeds from issuing equity | — | 4,968 | 310,424 | 785,084 | — | — |
| Proceeds from long-term debt | — | — | — | — | — | 1,300 |
| Net cash from financing activities | — | 4,580 | 2,092 | 4,222 | 1 | 12,786 |
| Net change in cash | — | 204 | (5,024) | 570 | (2,531) | 3,502 |
- † Share count changed about 1/17 in the period ending 2022-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 5x in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Compare with peers
SIC 3842 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3842 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| ENvue Medical | 1,084 | 239 | (2,691)* | 11.1M | 0.4 quarters | 10-QJun 30, 2026 |
| SeaStar Medical Holding | 6,959 | 615 | (2,994)* | 4.4M | 2.3 quarters | 10-QJun 30, 2026 |
| Tenon Medical | 1,677 | 1,279 | (2,758)* | 667,047 | 0.6 quarters | 10-QJun 30, 2026 |
| Bone Biologics | 6,088 | not reported | (532)* | 3.4M | 9.8 quarters | 10-QSep 30, 2026 |
| Sintx Technologies | 3,590 | 452 | (2,767)* | 6.7M | 1.3 quarters | 10-QJun 30, 2026 |
| OSR Health | 1,500 | 316 | (2,421)* | 35.1M | 0.6 quarters | 10-QJun 30, 2026 |
| Adm Tronics Unlimited | 223 | not reported | (33) | 67.6M | 6.8 quarters | 10-QJun 30, 2026 |
| Retractable Technologies | 2,641 | 7,201 | (1,732)* | 29.9M | 1.5 quarters | 10-QJun 30, 2026 |
| Sonoma Pharmaceuticals | 5,338 | 6,406 | (649) | 4.8M | 8.2 quarters | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.